Literature DB >> 29359690

From Latent Tuberculosis Infection to Tuberculosis. News in Diagnostics (QuantiFERON-Plus).

Dagmara I Borkowska1, Agnieszka M Napiórkowska1, Sylwia A Brzezińska1, Monika Kozińska1, Anna T Zabost1, Ewa M Augustynowicz-Kopeć1.   

Abstract

It is estimated that one third of the world's population have latent tuberculosis infection and that this is a significant reservoir for future tuberculosis cases. Most cases occur within two years following initial infection. The identification of individuals with latent tuberculosis infection is difficult due to the lack of an ideal diagnostic assay and incomplete understanding of latent infection. Currently, there are three tests: the oldest tuberculin skin test, T-SPOT.TB and the latest QuantiFERON-Plus for the detection of Mycobacterium tuberculosis infection. The interpretation of the test results must be used in the conjunction with a patient's epidemiological history, risk assessment, current clinical status, radiography and microbiological methods to ensure accurate diagnosis.

Entities:  

Keywords:  Mycobacterium tuberculosis; Tuberculosis; interferon-gamma release assays; latent tuberculosis infection; tuberculin skin test

Mesh:

Substances:

Year:  2017        PMID: 29359690     DOI: 10.5604/17331331.1234987

Source DB:  PubMed          Journal:  Pol J Microbiol        ISSN: 1733-1331


  4 in total

1.  Detecting tuberculosis in pregnant and postpartum women in Eswatini.

Authors:  Munyaradzi Pasipamire; Edward Broughton; Mandzisi Mkhontfo; Gugu Maphalala; Batsabile Simelane-Vilane; Samson Haumba
Journal:  Afr J Lab Med       Date:  2020-07-30

2.  QuantiFERON-TB Gold Plus Test in Diagnostics of Latent Tuberculosis Infection in Children Aged 1-14 in a Country with a Low Tuberculosis Incidence.

Authors:  Dagmara Borkowska-Tatar; Maria Krasińska; Ewa Augustynowicz-Kopeć
Journal:  Pol J Microbiol       Date:  2021-12-23

3.  Characterization of Two New Multidrug-Resistant Strains of Mycobacterium smegmatis: Tools for Routine In Vitro Screening of Novel Anti-Mycobacterial Agents.

Authors:  Patrick K Arthur; Vincent Amarh; Precious Cramer; Gloria B Arkaifie; Ethel J S Blessie; Mohammed-Sherrif Fuseini; Isaac Carilo; Rebecca Yeboah; Leonard Asare; Brian D Robertson
Journal:  Antibiotics (Basel)       Date:  2019-01-02

4.  Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study.

Authors:  Ewa Augustynowicz-Kopeć; Izabela Siemion-Szcześniak; Anna Zabost; Dorota Wyrostkiewicz; Dorota Filipczak; Karina Oniszh; Dariusz Gawryluk; Elżbieta Radzikowska; Damian Korzybski; Monika Szturmowicz
Journal:  Pol J Microbiol       Date:  2019
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.